Loading cancer entity…
Loading cancer entity…
Clinical trials
6,745 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,044)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00161278 | Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling | terminated | Phase 2 | 1 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 30, 2008 | clinicaltrials |
| NCT00535015 | Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer | terminated | Phase 2 | 70 | AnaborexINDUSTRY | 2 | Jul 22, 2008 | clinicaltrials |
| NCT00690703 | Radiofrequency Ablation of Pulmonary Tumors Response Evaluation(RAPTURE) | completed | Phase 2 | 106 | Angiodynamics, Inc.INDUSTRY | 5 | Jun 5, 2008 | clinicaltrials |
| NCT00217282 | Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 45 | Mt. Sinai Medical Center, MiamiOTHER | 1 | May 22, 2008 | clinicaltrials |
| NCT00678964 | Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(TIE) | unknown | Phase 2 | 260 | LungenClinic GrosshansdorfOTHER | 1 | May 16, 2008 | clinicaltrials |
| NCT00673777 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | May 14, 2008 | clinicaltrials |
| NCT00674258 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | May 14, 2008 | clinicaltrials |
| NCT00663689 | Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer | unknown | Phase 2 | 45 | Guangdong Provincial People's HospitalOTHER | 0 | Apr 22, 2008 | clinicaltrials |
| NCT00139711 | Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer | completed | Phase 2 | 138 | PfizerINDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00263016 | Docetaxel in Non Small Cell Lung Cancer (NSCLC) | terminated | Phase 2 | 50 | SanofiINDUSTRY | 1 | Mar 20, 2008 | clinicaltrials |
| NCT00343720 | Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy | completed | Phase 2 | — | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 13, 2008 | clinicaltrials |
| NCT00379717 | Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 1 / Phase 2 | 30 | Universitair Ziekenhuis BrusselOTHER | 1 | Mar 13, 2008 | clinicaltrials |
| NCT00319514 | Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC | completed | Phase 2 | 78 | Gachon University Gil Medical CenterOTHER | 1 | Mar 12, 2008 | clinicaltrials |
| NCT00319800 | Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC | unknown | Phase 2 | 50 | Gachon University Gil Medical CenterOTHER | 1 | Mar 12, 2008 | clinicaltrials |
| NCT00001450 | Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC | completed | Phase 2 | 58 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001499 | Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00278070 | Metronomic Oral Vinorelbine in Patients With Metastatic Tumors | completed | Phase 2 | — | Hellenic Cooperative Oncology GroupOTHER | 1 | Feb 29, 2008 | clinicaltrials |
| NCT00625352 | Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma | unknown | Phase 2 | 48 | Ulsan University HospitalOTHER | 1 | Feb 28, 2008 | clinicaltrials |
| NCT00614809 | Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer | unknown | Phase 2 | 45 | Guangdong Provincial People's HospitalOTHER | 0 | Feb 22, 2008 | clinicaltrials |
| NCT00051974 | Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 155 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00095225 | A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) | completed | Phase 2 | 122 | Genentech, Inc.INDUSTRY | 1 | Jan 29, 2008 | clinicaltrials |
| NCT00466089 | Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer | unknown | Phase 2 | 90 | Hospital of NavarraOTHER | 1 | Jan 10, 2008 | clinicaltrials |
| NCT00328588 | LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy | completed | Phase 2 | 37 | Astellas Pharma IncINDUSTRY | 3 | Jan 2, 2008 | clinicaltrials |
| NCT00034346 | ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | 194 | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00089726 | A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 100 | Cell GenesysINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00120679 | Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00069875 | A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer | completed | Phase 2 | 195 | Eli Lilly and CompanyINDUSTRY | 6 | Dec 21, 2007 | clinicaltrials |
| NCT00578149 | Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer | completed | Phase 2 | 45 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00333294 | Phase II Iressa + Irradiation Followed by Chemo in NSCLC | completed | Phase 2 | 50 | AstraZenecaINDUSTRY | 1 | Dec 19, 2007 | clinicaltrials |
| NCT00073151 | A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 30 | AbbottINDUSTRY | 1 | Nov 29, 2007 | clinicaltrials |
| NCT00561054 | Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC(Coimbra) | unknown | Phase 2 | 47 | Grupo Portugues de Estudo do Cancro do PulmaoOTHER | 1 | Nov 20, 2007 | clinicaltrials |
| NCT00259675 | Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC | completed | Phase 2 | 100 | University of SaskatchewanOTHER | 1 | Nov 15, 2007 | clinicaltrials |
| NCT00081315 | Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer | completed | Phase 2 | 130 | MedImmune LLCINDUSTRY | 1 | Aug 21, 2007 | clinicaltrials |
| NCT00061646 | Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 2 | 25 | AbbottINDUSTRY | 1 | Aug 14, 2007 | clinicaltrials |
| NCT00173875 | Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer | completed | Phase 2 | 108 | National Taiwan University HospitalOTHER | 1 | Jul 30, 2007 | clinicaltrials |
| NCT00490659 | Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes | completed | Phase 2 | 13 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 25, 2007 | clinicaltrials |
| NCT00489983 | Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy | completed | Phase 2 | 91 | Eli Lilly and CompanyINDUSTRY | 3 | Jun 22, 2007 | clinicaltrials |
| NCT00489996 | Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer | completed | Phase 2 | 100 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 22, 2007 | clinicaltrials |
| NCT00066885 | Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 80 | NovaceaINDUSTRY | 1 | May 7, 2007 | clinicaltrials |
| NCT00034827 | A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer | completed | Phase 2 | 172 | PfizerINDUSTRY | 1 | May 4, 2007 | clinicaltrials |
| NCT00105092 | Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer. | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | May 1, 2007 | clinicaltrials |
| NCT00466284 | Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer | unknown | Phase 2 | 46 | Grupo Gallego de Cancer de PulmonOTHER | 1 | Apr 27, 2007 | clinicaltrials |
| NCT00425022 | VATS Lobectomy for Clinical Stage IB or II Lung Cancer | unknown | Phase 2 | 40 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 30, 2007 | clinicaltrials |
| NCT00061464 | Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy. | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00190840 | A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 186 | Eli Lilly and CompanyINDUSTRY | 8 | Jan 26, 2007 | clinicaltrials |
| NCT00191230 | Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191256 | Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer | completed | Phase 2 | 77 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191490 | A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer | completed | Phase 2 | 162 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191620 | Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer. | completed | Phase 2 | 64 | Eli Lilly and CompanyINDUSTRY | 4 | Jan 26, 2007 | clinicaltrials |
| NCT00260026 | Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer | completed | Phase 2 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Jul 30, 2008source: clinicaltrials